What Are the Types of Ovarian Cancer?

Ovarian cancer is not one single disease wearing one dramatic hat. It is more like a complicated family reunion: several related cancers, each with its own personality, behavior, favorite hiding places, and treatment considerations. Understanding the different types of ovarian cancer can help patients, caregivers, and curious readers make sense of medical terms that may otherwise sound like someone dropped a biology textbook into a blender.

At the simplest level, ovarian cancers are usually grouped by the kind of cell where the cancer begins. The three main types are epithelial ovarian cancer, germ cell ovarian tumors, and sex cord-stromal ovarian tumors. Doctors may also discuss fallopian tube cancer and primary peritoneal cancer alongside ovarian cancer because they can look and behave very similarly, especially when the cancer is epithelial in origin.

This guide explains the major ovarian cancer types, common subtypes, how they differ, and why the exact diagnosis matters. The goal is not to replace a doctor’s advice, but to make the vocabulary less intimidating. Because when medical words stop sounding like secret passwords, people can ask better questions and feel more prepared.

Why Ovarian Cancer Type Matters

The type of ovarian cancer affects how it may grow, when it is usually diagnosed, which tests are helpful, what treatments may be recommended, and what follow-up care may look like. Two people can both be told they have “ovarian cancer,” but their cancers may act very differently under the microscope.

For example, high-grade serous carcinoma, the most common epithelial subtype, often grows aggressively and may be diagnosed after it has spread beyond the ovaries. A germ cell tumor, on the other hand, may appear in a much younger person and may respond very well to treatment. A stromal tumor may produce hormones, which can cause unusual bleeding or other symptoms earlier than expected. Same neighborhood, very different residents.

The Three Main Types of Ovarian Cancer

1. Epithelial Ovarian Cancer

Epithelial ovarian cancer is the most common type of ovarian cancer. It begins in epithelial cells, which are cells that line surfaces and organs. In ovarian cancer discussions, epithelial cancers may involve the ovary, fallopian tube, or peritoneum, the thin tissue lining the abdomen and pelvis.

This category includes several important subtypes. The subtype is not just a fancy label. It gives doctors clues about how the cancer developed, how fast it may grow, and which treatments may be most useful.

High-Grade Serous Carcinoma

High-grade serous carcinoma is the most common and often the most aggressive epithelial ovarian cancer subtype. Many cases are now believed to begin in the fallopian tube rather than the ovary itself. This discovery has changed how researchers think about prevention, early detection, and risk-reducing surgery.

High-grade serous carcinoma is often diagnosed at an advanced stage because early symptoms can be vague. Bloating, pelvic pressure, feeling full quickly, urinary changes, and abdominal discomfort may be easy to blame on digestion, stress, or the burrito that seemed like a good idea at lunch. Unfortunately, these symptoms can also be warning signs when they are persistent, new, and unusual for the person.

Low-Grade Serous Carcinoma

Low-grade serous carcinoma is less common than high-grade serous carcinoma and typically grows more slowly. It may affect younger patients compared with high-grade disease. Although the word “low-grade” may sound reassuring, this cancer can still be serious and may be less responsive to standard chemotherapy than high-grade serous tumors.

Treatment may involve surgery, chemotherapy, hormonal therapy, targeted therapy, or a combination depending on the stage and individual medical details. This is one reason the exact pathology report matters so much. “Ovarian cancer” is the headline, but the subtype is the plot twist.

Endometrioid Ovarian Cancer

Endometrioid ovarian cancer is another epithelial subtype. It can be associated with endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus. Endometrioid tumors may sometimes be found at an earlier stage than high-grade serous carcinoma.

Some endometrioid ovarian cancers may occur alongside endometrial cancer, which starts in the lining of the uterus. Because of this, doctors may carefully evaluate the uterus and other pelvic organs during diagnosis and treatment planning.

Clear Cell Ovarian Cancer

Clear cell ovarian cancer is a rarer epithelial subtype. Like endometrioid cancer, it has been linked with endometriosis. It may be diagnosed at an earlier stage in some patients, but when advanced, it can be challenging because it may not respond to chemotherapy as well as some other ovarian cancer types.

The name “clear cell” comes from how the cancer cells look under a microscope. They are not actually clear in the emotional sense. They do not politely explain themselves, send calendar reminders, or make the diagnosis easy. Pathologists identify them by their appearance, and that identification helps guide treatment decisions.

Mucinous Ovarian Cancer

Mucinous ovarian cancer is another uncommon epithelial subtype. These tumors can become very large before they are discovered, sometimes because they grow as a mass rather than spreading early. When caught at an early stage, mucinous ovarian cancer may have a better outlook. Advanced mucinous disease can be more difficult to treat.

Doctors also work carefully to determine whether a mucinous tumor truly started in the ovary or spread there from another organ, such as the gastrointestinal tract. This distinction matters because treatment may differ depending on the original source.

Borderline Ovarian Tumors

Borderline ovarian tumors, also called tumors of low malignant potential, are epithelial tumors that are not clearly benign but do not behave like typical invasive ovarian cancers. They tend to grow more slowly and are often diagnosed at an earlier stage.

Borderline tumors may require surgery, but the treatment approach can differ from invasive ovarian cancer. In some cases, fertility-sparing surgery may be discussed for younger patients who wish to preserve the possibility of pregnancy. As always, this depends on the tumor, stage, and medical team’s evaluation.

2. Germ Cell Ovarian Tumors

Germ cell ovarian tumors begin in the cells that produce eggs. Most ovarian germ cell tumors are benign, meaning they are not cancer. When they are malignant, they are rare compared with epithelial ovarian cancer and are more likely to occur in children, teenagers, and young adults.

One important feature of malignant germ cell tumors is that many are highly treatable, especially when diagnosed early. Treatment often includes surgery, and chemotherapy may be used depending on the tumor type and stage. Fertility preservation may also be part of the conversation because these tumors often affect younger patients.

Dysgerminoma

Dysgerminoma is one of the more common malignant ovarian germ cell tumors. It often affects adolescents and young women. Dysgerminomas are usually sensitive to treatment, and outcomes can be favorable, particularly when the cancer is found early.

Immature Teratoma

Immature teratoma is a malignant germ cell tumor that contains immature tissues. It is different from a mature teratoma, also known as a dermoid cyst, which is usually benign. Teratomas are famous for being strange because they can contain tissues such as hair, skin, or teeth. The human body occasionally has the creative direction of a surrealist painter.

Yolk Sac Tumor

Yolk sac tumors, also called endodermal sinus tumors, are rare but can grow quickly. They may produce a tumor marker called alpha-fetoprotein, or AFP, which can help with diagnosis and monitoring response to treatment.

Other Germ Cell Tumors

Other malignant germ cell tumors include embryonal carcinoma, choriocarcinoma, and mixed germ cell tumors. Mixed tumors contain more than one germ cell tumor type. Because these cancers are rare, care from specialists familiar with gynecologic cancers is especially important.

3. Sex Cord-Stromal Ovarian Tumors

Sex cord-stromal ovarian tumors begin in the supportive tissue of the ovary. These tissues help hold the ovary together and produce hormones such as estrogen, progesterone, and androgens. Stromal tumors are rare, but they are important because they may cause hormone-related symptoms.

Some stromal tumors are diagnosed earlier than epithelial ovarian cancers because hormone changes can create noticeable clues. These may include abnormal vaginal bleeding, bleeding after menopause, early puberty symptoms in children, or signs of increased androgen levels such as excess facial hair or voice changes.

Granulosa Cell Tumors

Granulosa cell tumors are among the better-known sex cord-stromal tumors. They may produce estrogen, which can lead to irregular periods or postmenopausal bleeding. Many granulosa cell tumors grow slowly, but they can recur years later, so long-term follow-up is often important.

Sertoli-Leydig Cell Tumors

Sertoli-Leydig cell tumors are rare stromal tumors that may produce androgens, sometimes called male-type hormones. Symptoms can include acne, facial hair growth, deepening of the voice, or changes in menstrual patterns.

Other Stromal Tumors

Other stromal tumors include theca cell tumors, fibromas, and mixed sex cord-stromal tumors. Some are benign, while others are malignant. The pathology report and staging workup help determine the seriousness of the diagnosis and the best treatment plan.

Related Cancers Often Grouped With Ovarian Cancer

Fallopian Tube Cancer

Fallopian tube cancer begins in the tubes that connect the ovaries to the uterus. Many high-grade serous cancers once thought to start in the ovary may actually begin in the fallopian tube. Because these cancers behave similarly, they are often diagnosed and treated like epithelial ovarian cancer.

Primary Peritoneal Cancer

Primary peritoneal cancer begins in the peritoneum, the tissue lining the abdomen and pelvis. It can look almost identical to epithelial ovarian cancer under the microscope and may occur even after the ovaries have been removed. Symptoms and treatment are often similar to those for advanced epithelial ovarian cancer.

Common Symptoms Across Ovarian Cancer Types

Symptoms can vary by type, but several warning signs are commonly discussed across ovarian cancers. These include persistent bloating, pelvic or abdominal pain, feeling full quickly, trouble eating, urinary urgency or frequency, constipation, back pain, fatigue, and abnormal vaginal bleeding or discharge.

The key word is persistent. Everyone gets bloated now and then. Everyone has a weird stomach day. The concern rises when symptoms are new, frequent, worsening, or unusual for your body. If symptoms continue for more than a couple of weeks, it is reasonable to contact a healthcare professional.

Risk Factors and Genetics

Risk factors for ovarian cancer can include increasing age, family history of ovarian or breast cancer, inherited gene mutations such as BRCA1 and BRCA2, Lynch syndrome, endometriosis, and a personal history of certain cancers. Having a risk factor does not mean someone will develop ovarian cancer, and having no obvious risk factor does not make ovarian cancer impossible.

Genetic counseling and testing may be recommended for people with a strong family history or a diagnosis of certain ovarian cancers. This information can guide treatment, help estimate risk for relatives, and support decisions about prevention.

Screening and Early Detection: The Frustrating Truth

Unlike cervical cancer, ovarian cancer does not have a reliable routine screening test for people at average risk. Tests such as CA-125 blood testing and transvaginal ultrasound can be useful in evaluating symptoms or monitoring known disease, but they are not recommended as routine screening tools for average-risk, symptom-free people because they have not been shown to reduce deaths and can lead to false positives, anxiety, and unnecessary surgery.

For people at high risk, such as those with certain inherited mutations, doctors may recommend a personalized plan. This may include genetic counseling, discussion of risk-reducing surgery, and sometimes surveillance while decisions are being made. The best approach depends on age, family history, mutation status, fertility goals, and overall health.

How Doctors Identify the Type

The exact ovarian cancer type is usually confirmed through pathology, which means tissue is examined under a microscope. Imaging tests, blood tests, tumor markers, surgical findings, and genetic testing may also help build the full picture.

For example, CA-125 may be elevated in epithelial ovarian cancer but is not specific to cancer. AFP may be useful in some germ cell tumors. Inhibin may be helpful in some granulosa cell tumors. These markers are tools, not magic wands. Doctors interpret them along with symptoms, imaging, pathology, and clinical judgment.

Treatment Differences by Type

Treatment often starts with surgery, especially when doctors need to remove a tumor, determine the stage, and confirm the diagnosis. Chemotherapy is common for many epithelial ovarian cancers and some malignant germ cell tumors. Targeted therapies, including PARP inhibitors or anti-angiogenic therapy, may be recommended for certain epithelial cancers depending on genetic findings and disease features.

Stromal tumors may sometimes be managed with surgery alone if found early, though additional treatment may be needed in higher-risk cases. Hormonal therapy may be considered for certain low-grade or hormone-sensitive tumors. Germ cell tumors may require chemotherapy, but fertility-sparing approaches are often possible in selected patients.

The best treatment plan is individualized. It depends on the cancer type, subtype, stage, grade, genetic markers, age, fertility goals, overall health, and patient preferences. In other words, treatment planning is not a vending machine. You do not push “B7” and receive one standard answer.

Experience-Based Perspective: What People Often Learn After Hearing the Diagnosis

Many people first hear the words “ovarian cancer” and immediately imagine one single disease. One of the most common experiences after diagnosis is discovering that the label is only the beginning. The next questions quickly become: What type? What stage? What grade? Did it start in the ovary, fallopian tube, or peritoneum? Are there genetic mutations? Is fertility preservation possible? Suddenly, the conversation has more layers than a very ambitious lasagna.

Patients often describe the early period as confusing because symptoms may have seemed ordinary. Bloating may have felt like a digestive issue. Pelvic pressure may have been blamed on aging, stress, or exercise. Feeling full quickly may have seemed harmless at first. This is one reason symptom awareness matters. It is not about panicking over every stomach rumble. It is about noticing patterns that are new, persistent, and out of character.

Another common experience is learning how important the pathology report is. Patients may initially focus on the word “cancer,” which is completely understandable. But the pathology details can shape everything that follows. A high-grade serous carcinoma, a mucinous tumor, a dysgerminoma, and a granulosa cell tumor are not interchangeable. They may require different specialists, different tumor markers, different treatment choices, and different follow-up plans.

People with rare ovarian cancer types often face a second challenge: explaining their diagnosis again and again. Friends may have heard of ovarian cancer but not clear cell carcinoma, immature teratoma, or Sertoli-Leydig cell tumors. This can make patients feel like they are carrying both the illness and the job of medical translator. For these patients, seeking care from a gynecologic oncologist and asking whether the team has experience with rare ovarian tumors can be especially valuable.

Caregivers also go through a learning curve. At first, many want to help but do not know what to say. Practical support often matters more than perfect words. Driving to appointments, organizing medication lists, taking notes during consultations, cooking gentle meals, or simply sitting quietly can be deeply helpful. Cancer does not always need a motivational speech. Sometimes it needs a ride, a notebook, and someone who remembers where the parking ticket went.

For younger patients with germ cell tumors or certain borderline tumors, fertility questions may arrive quickly and emotionally. Some people want future pregnancy options; others do not. Either way, they deserve clear information before treatment begins when time and safety allow. Fertility-sparing surgery may be possible in selected cases, but it depends on the tumor type and stage.

Many patients also learn that follow-up is part of the journey, not an afterthought. Some ovarian cancers can recur, and certain slow-growing tumors may return years later. Follow-up visits, blood tests, scans when needed, and symptom tracking can feel stressful, but they are also tools for staying ahead of changes.

The most empowering experience many people report is learning to ask specific questions. “What type of ovarian cancer do I have?” “What subtype?” “What stage and grade?” “Were genetic tests done?” “Should my family consider genetic counseling?” “What symptoms should I report right away?” These questions turn a frightening diagnosis into a more understandable plan. They do not make ovarian cancer easy, but they can make the road less foggy.

Conclusion

Ovarian cancer includes several distinct diseases, not just one. The main types are epithelial ovarian cancer, germ cell ovarian tumors, and sex cord-stromal ovarian tumors. Epithelial ovarian cancer is the most common and includes subtypes such as high-grade serous, low-grade serous, endometrioid, clear cell, and mucinous carcinoma. Germ cell tumors tend to affect younger people and are often highly treatable. Stromal tumors are rare and may produce hormones that cause noticeable symptoms.

Knowing the exact type of ovarian cancer helps guide treatment, follow-up, genetic testing, and conversations about fertility or family risk. If symptoms such as bloating, pelvic pain, urinary changes, feeling full quickly, or abnormal bleeding are persistent and unusual, they deserve medical attention. The body may not speak in complete sentences, but it does send memos. It is wise to read them.

Medical note: This article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Anyone with symptoms, risk factors, or a recent diagnosis should speak with a qualified healthcare professional or gynecologic oncologist.